Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
34,723,329
-
Total 13F shares
-
10,035,118
-
Share change
-
+10,035,118
-
Total reported value
-
$178,125,000
-
Price per share
-
$17.75
-
Number of holders
-
33
-
Value change
-
+$178,125,000
-
Number of buys
-
33
Institutional Holders of IGM Biosciences, Inc. - Common Stock, par value $0.01 per share (IGMS) as of Q3 2019
As of 30 Sep 2019,
IGM Biosciences, Inc. - Common Stock, par value $0.01 per share (IGMS) was held by
33 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
10,035,118 shares.
The largest 10 holders included
BAKER BROS. ADVISORS LP, Redmile Group, LLC, PRICE T ROWE ASSOCIATES INC /MD/, JANUS HENDERSON GROUP PLC, RA CAPITAL MANAGEMENT, L.P., HILLHOUSE CAPITAL ADVISORS, LTD., MILLENNIUM MANAGEMENT LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), Artal Group S.A., and Cormorant Asset Management, LP.
This page lists
33
institutional shareholders reporting positions in this security
for the Q3 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.